TRCA Tercica (MM)

Tercica, Inc. (NASDAQ: TRCA) today announced that company management will present at the FBR Capital Markets 12th Annual Spring Investor Conference on Wednesday, May 28, 2008 at 2:20 p.m. Eastern time. The conference will be held at the Grand Hyatt New York. Interested individuals may access a live audio and slide webcast of the conference presentation via the Internet by visiting the Investors section of the Company�s Web site at www.tercica.com. An archived presentation will be available on the Web site for 21 days. About Tercica Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for pediatric and adult growth disorders, and for adult metabolic disorders. For further information on Tercica, please visit www.tercica.com.